Chip Stocks to Buy After Their Worst Day Since June

The PHLX Semiconductor Index fell 6.7% on Oct. 22, its worst session since June 23, amid supply constraints flagged by Lam Research; Lam shares dropped 12%, Micron 6%, AMD 8% and Marvell 9%. The article argues the constraints reflect demand exceeding supply, noting Micron expects record fiscal Q1 2027 revenue of about $61.5 billion and AMD expects data-center sales to more than double next year, while Marvell’s fiscal 2031 targets imply adjusted earnings above $30 per share at the midpoint. The author views the sell-off as a buying opportunity, favoring Micron, while noting that AMD and Marvell valuations depend on their growth plans and that weaker AI spending remains a risk.

Analysis

The market is treating supply constraints as a sector-wide demand warning; the more useful distinction is where scarcity lands in the income statement. For MU, tight memory supply can support pricing before new capacity arrives, but that advantage reverses quickly if AI-related demand or customer inventory turns. For AMD and MRVL, constrained advanced-wafer and packaging capacity can cap shipments even if demand remains strong; MRVL’s distant earnings ambition is especially exposed to execution slippage and discount-rate sensitivity. LRCX has a two-sided exposure: equipment demand is supportive, but clean-room and component bottlenecks can defer shipments and revenue recognition, so demand strength does not guarantee near-term upside.

Over the next 1–3 months, watch memory pricing and company guidance, plus evidence that foundry/packaging capacity is actually expanding—not just management intent. Over 6–18 months, the key question is whether capacity additions arrive ahead of AI demand or after it. A slowdown in AI infrastructure spending would hit the high-expectation names first and could also turn today’s memory pricing strength into a cycle peak. Contrarian opportunity is strongest in MU if the market is discounting an earnings reversal despite continued pricing support; the counterpoint is that low apparent forward multiples are not protection against peak-cycle earnings.

Key Decisions for Investors

• Favor a staged long in MU over the other named chipmakers: add on further volatility rather than chase, and reassess if memory pricing momentum fades or management lowers its fiscal-year outlook. The thesis is pricing-led earnings resilience, not a claim that memory is non-cyclical.
• Treat AMD as a watch/add-on-pullbacks position, not a supply-constrained breakout trade. Verify that advanced wafer and packaging availability improves enough to support data-center growth; a guidance reduction or repeated shipment constraints would falsify the upside case.
• Avoid underwriting MRVL’s fiscal 2031 target as near-term valuation support. Consider underweighting it versus MU until growth converts into delivered revenue and margins; the relative thesis fails if MRVL accelerates revenue while MU’s pricing or guidance rolls over.
• Do not buy LRCX solely on industry spending forecasts. Track whether clean-room and parts bottlenecks ease and whether equipment orders convert into shipments; persistent delays could postpone revenue despite healthy end demand.